| Literature DB >> 30425146 |
Andrés Corral-Lugo1, Miguel A Matilla1, David Martín-Mora1, Hortencia Silva Jiménez1, Noel Mesa Torres1, Junichi Kato2, Akiko Hida2, Shota Oku2, Mayte Conejero-Muriel3, Jose A Gavira4, Tino Krell5.
Abstract
Histamine is a key biological signaling molecule. It acts as a neurotransmitter in the central and peripheral nervous systems and coordinates local inflammatory responses by modulating the activity of different immune cells. During inflammatory processes, including bacterial infections, neutrophils stimulate the production and release of histamine. Here, we report that the opportunistic human pathogen Pseudomonas aeruginosa exhibits chemotaxis toward histamine. This chemotactic response is mediated by the concerted action of the TlpQ, PctA, and PctC chemoreceptors, which display differing sensitivities to histamine. Low concentrations of histamine were sufficient to activate TlpQ, which binds histamine with an affinity of 639 nM. To explore this binding, we resolved the high-resolution structure of the TlpQ ligand binding domain in complex with histamine. It has an unusually large dCACHE domain and binds histamine through a highly negatively charged pocket at its membrane distal module. Chemotaxis to histamine may play a role in the virulence of P. aeruginosa by recruiting cells at the infection site and consequently modulating the expression of quorum-sensing-dependent virulence genes. TlpQ is the first bacterial histamine receptor to be described and greatly differs from human histamine receptors, indicating that eukaryotes and bacteria have pursued different strategies for histamine recognition.IMPORTANCE Genome analyses indicate that many bacteria possess an elevated number of chemoreceptors, suggesting that these species are able to perform chemotaxis to a wide variety of compounds. The scientific community is now only beginning to explore this diversity and to elucidate the corresponding physiological relevance. The discovery of histamine chemotaxis in the human pathogen Pseudomonas aeruginosa provides insight into tactic movements that occur within the host. Since histamine is released in response to bacterial pathogens, histamine chemotaxis may permit bacterial migration and accumulation at infection sites, potentially modulating, in turn, quorum-sensing-mediated processes and the expression of virulence genes. As a consequence, the modulation of histamine chemotaxis by signal analogues may result in alterations of the bacterial virulence. As the first report of bacterial histamine chemotaxis, this study lays the foundation for the exploration of the physiological relevance of histamine chemotaxis and its role in pathogenicity.Entities:
Keywords: Pseudomonas aeruginosa; chemotaxis; histamine
Mesh:
Substances:
Year: 2018 PMID: 30425146 PMCID: PMC6234866 DOI: 10.1128/mBio.01894-18
Source DB: PubMed Journal: MBio Impact factor: 7.867
FIG 1Thermal shift assays of P. putida KT2440 McpU-LBD against a library of ligands. Shown are the individual T changes caused by 95 compounds (Biolog array PM3B) that can serve as nitrogen sources. The inset shows the unfolding curves of McpU-LBD when free from ligand (continuous line) and in the presence of agmatine (dotted line) and histamine (dashed line).
Thermodynamic parameters for the binding of ligands to McpU-LBD and TlpQ-LBD as derived from ITC experiments
| Compound | McpU-LBD | TlpQ-LBD | |||
|---|---|---|---|---|---|
| Δ | Δ | ||||
| Putrescine | 2 ± 0.1 | −15 ± 0.5 | 134 ± 12 | −6.8 ± 0.3 | 15 |
| Cadaverine | 22 ± 2 | −15.5 ± 0.5 | 150 ± 4 | −6.0 ± 0.1 | 147 |
| Spermidine | 4.5 ± 0.4 | −4.3 ± 0.3 | 56 ± 4 | −4.6± 0.4 | 80 |
| Agmatine | 0.48 ± 0.02 | −14.5 ± 0.2 | 150 ± 9 | −5.4 ± 0.1 | 3 |
| Ethylenediamine | 39 ± 4 | −9.7 ± 0.5 | 1,710 ± 180 | −6.3 ± 0.6 | 23 |
| Histamine | 26 ± 2 | −2.6 ± 0.3 | 639 ± 27 | −9.1 ± 0.3 | 41 |
Means and standard deviations represent data from three independent experiments.
Reported previously in reference 20.
FIG 2Identification and analysis of TlpQ ligands. (A) Microcalorimetric titrations of 15 µM TlpQ-LBD with 4.8 µl aliquots of 250 µM putrescine, spermidine, or cadaverine. (B) Microcalorimetric titration of 17.5 µM McpU-LBD with 9.6 µl aliquots of 1 mM histamine and titration of 15 µM TlpQ-LBD with 4.8 µl aliquots of 250 µM histamine. Upper graphs show raw titration data, while lower graphs show integrated corrected peak areas of the titration data fit using the “one binding site model.” The derived thermodynamic parameters are provided in Table 1. (C) Quantitative capillary chemotaxis assays of P. aeruginosa PAO1 toward TlpQ ligands. Shown are the ratios of cells after 2 min of exposure to the chemoattractant relative to the number of cells at the beginning of the experiment. The horizontal line marks the ratio of 1, which is indicative of no chemotaxis; n = 3.
FIG 3Histamine chemotaxis in different bacteria. (A) Quantitative capillary chemotaxis assays of P. aeruginosa PAO1 and P. putida KT2440 to different histamine concentrations. (B) Response of different strains to 5 mM histamine; n = 3. **, P < 0.01 (by Student’s t tests).
FIG 4Structure of the TlpQ chemoreceptor ligand binding domain in complex with histamine. (A) Ribbon diagram with annotated secondary structure elements. Bound histamine is shown as a stick structure. (B) Schematic representation of the secondary structure elements.
FIG 5Ligand binding pocket of the TlpQ ligand binding domain. (A) Close-up view of the ligand binding pocket. The electron density for histamine is shown. (B) Surface charge representation of the histamine binding site; red and blue shading represent negative and positive charges, respectively. (C) Schematic representation of amino acids involved in hydrogen bonds with histamine. (D) Superimposition of the ligand binding pockets of McpU-LBD with bound putrescine (green, PDB ID 6F9G) and TlpQ-LBD with bound histamine (blue).
FIG 6Chemotaxis to histamine is mediated by multiple chemoreceptors in P. aeruginosa PAO1. (A) Chemotactic responses to 5 mM histamine by wild-type and mutant strains. (B) Histamine dose-response chemotaxis assays for PAO1 and for PCT2 and PCT2Q mutants. (C) Chemotactic response of PAO1 and PCT2Q harboring plasmids pPctA, pPctB, pPctC, and pTlpQ to 500 µM histamine after contact times of 1 min and 2.5 min; n = 3. *, P < 0.05; **, P < 0.01 (by Student’s t tests).
Bacterial strains and plasmids used in this study
| Strain or plasmid | Characteristics | Reference or source |
|---|---|---|
| Strains | ||
| | F−
| |
| DH5α | ||
| HB101 | F− Δ( | |
| JM109 | F′ | |
| S17-1 λ | Tpr Smr ( | |
| | Wild-type strain race 1, biovar 3, phylotype I | |
| | Wild type | |
| KT2440R | Rifampicin-resistant derivative of KT2440 | |
| KT2440R-McpU | KT2440R transposon mutant | |
| | Wild-type strain | |
| PAO1 Δ | PAO1 derivative, | This study |
| PCTB1 | PAO1 derivative, | |
| PCTC1 | PAO1 derivative, | |
| PAO1 Δ | PAO1 derivative, | This study |
| PCT2 | PAO1 derivative; Δ | |
| PCTAQ | PAO1 derivative; Δ | This study |
| PCT2Q | PAO1 derivative; Δ | This study |
| PCT2QP | PAO1 derivative; Δ | J. Kato lab |
| PCT2QART | PAO1 derivative; Δ | J. Kato lab |
| | Wild-type strain; human clinical isolate that elicits disease in plants, nematodes, insects, and mice | |
| PA14-ACQ | PA14 derivative; Δ | This study |
| | Isolated clinical strain from patients with urinary tract infections | |
| | Isolated clinical strain from patients with urinary tract infections | |
| | Isolated clinical strain from patients with urinary tract infections | |
| | Isolated clinical strain from patients with urinary tract infections | |
| | Isolated clinical strain from patients with urinary tract infections | |
| Plasmids | ||
| pUCP18 | ||
| pPctA | pUCP18 with a PCR fragment containing | |
| pPctB | pUCP18 with a PCR fragment containing | |
| pPctC | pUCP18 with a PCR fragment containing | This study |
| pTlpQ | pUCP18 with a PCR fragment containing | |
| pK18 | Plasmid for allelic exchange; pK18 | |
| pK18 | pK18 | This study |
| pK18 | pK18 | This study |
| pK18 | pK18 | This study |
| pK18 | pK18 | This study |
| pET28b(+) | Protein expression plasmid; Kmr | Novagen |
| pET28b-McpU | pET28b derivative used to produce His-tagged McpU-LBD; Kmr | |
| pET28b-TlpQ | pET28b derivative used to produce His-tagged TlpQ-LBD; Kmr | This study |
Ap, ampicillin; Km, kanamycin; Rif, rifampin.
The pa4308 gene (orf-1), which forms part of the pctABC operon, encodes a hypothetical protein that is not involved in chemotaxis (23).